<DOC>
	<DOCNO>NCT02619617</DOCNO>
	<brief_summary>The purpose study determine SOM230 safe effective treament cluster headache .</brief_summary>
	<brief_title>Safety Efficacy Study SOM230 s.c. Cluster Headache</brief_title>
	<detailed_description>The purpose non-confirmatory study determine SOM230 adequate efficacy safety warrant clinical development cluster headache ( CH ) . This study two part . Part A parallel design SOM230 v . Placebo , follow observe signal Part A interim analysis , Part B study comparison SOM230 sumatriptan .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>( Part A , Part B ) Subject male female age 1865 inclusive . Written informed consent must obtain assessment perform . Subjects must establish diagnosis episodic cluster headache ( CH ) chronic CH , average 26 headache attack per day last least 45 minute without treatment , exceed 6 attack per day within last year . Able communicate well investigator , understand comply requirement study , well accept NOT share study information social medium participation study . Subject able selfinject medication subcutaneously assistance partner outpatient basis . ( Part A , Part B ) Subjects history great 6 CH attack per day within last year . Women childbearing potential , defined woman physiologically capable become pregnant , unless use effective method contraception duration study . History multiple recur allergy allergy investigational compound/compound class use study . Use investigational drug time enrollment , within 5 halflives enrollment , within 30 day , whichever longer ; longer require local regulation . A history clinically significant heart disease , ECG abnormality , continue use drug know prolong QTc study conduct , follow ECG abnormality screen baseline : QTcF &gt; 450 msec ( male ) QTcF &gt; 460 msec ( female ) Uncontrolled diabetes evidence screen HbA1c &gt; 8.0 % A positive Hepatitis B surface antigen Hepatitis C test result . Acute cholecystitis symptomatic cholelithiasis subject without H/O cholecystectomy ( Part B Only ) History untreated uncontrolled hypertension , stroke , peripheral arterial disease ischemic bowel disease . History multiple recur allergy sumatriptan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cluster Headache</keyword>
	<keyword>Patient Diary collection headache pain</keyword>
	<keyword>Biomarker - saliva sample</keyword>
</DOC>